Severe fever with thrombocytopenia syndrome virus (SFTSV) is a novel 22 emerging virus that has been identified in China, South Korea, and Japan, and induces 23 thrombocytopenia and leukocytopenia in humans with a high case fatality rate. SFTSV 24 is pathogenic to humans, while immunocompetent adult mice and golden Syrian 25 hamsters infected with SFTSV never show apparent symptoms. However, mice 26 deficient for the gene encoding the chain of the interferon (IFN)  and  receptor 27 (Ifnar1 -/mice) and golden Syrian hamsters deficient for the gene encoding signal 28 transducer and activator of transcription 2 (Stat2 -/hamsters) are highly susceptible to 29 SFTSV infection, with infection resulting in death. The nonstructural protein (NSs) of 30 SFTSV has been reported to inhibit the type I IFN response through sequestration of 31 human STAT proteins. Here, we demonstrated that SFTSV induces lethal acute disease 32 in STAT2-deficient mice, but not in STAT1-deficient mice. Furthermore, we discovered 33 that NSs cannot inhibit type I IFN signaling in murine cells due to an inability to bind to 34 murine STAT2. Taken together, our results imply that the dysfunction of NSs in 35 antagonizing murine STAT2 can lead to inefficient replication and the loss of 36 pathogenesis of SFTSV in mice.
INTRODUCTION
These results indicate that Stat2 -/and Ifnar1 -/mice, but not Stat1 -/mice, are 131 highly susceptible to SFTSV infection, which suggests that STAT2 plays a critical role 132 in the suppression of SFTSV replication in mice. 133 134 SFTSV NSs cannot suppress type I IFN signaling in murine cells. 135 It has been reported that SFTSV suppress type I IFN signaling in human cells (13) . 136 Therefore, we hypothesized that SFTSV cannot suppress type I IFN signaling in murine 137 cells, and IFN-mediated innate immunity restricts SFTSV replication in mice. To Recently, SFTSV NSs has been reported to function as an IFN antagonist (13-15)., 145 Therefore, the effects of NSs on ISRE activation in HEK293T cells and NIH3T3 cells 146 were examined by DLR gene assay. In this experiment, the VP40 protein of 147 mouse-adapted Marburg virus (mMARV), which functions as an IFN signaling inhibitor in murine cells, was used as a positive control (20) . As shown in Fig. 3B , IFN-αA/D 149 treatment induced strong ISRE activation in both HEK293T and NIH3T3 cells. As 150 expected, the expression of SFTSV NSs significantly inhibited the ISRE activation 151 driven by IFN-αA/D in HEK293T cells, while NSs expression did not suppress this 152 activation in NIH3T3 cells (Fig. 3B ). We also confirmed that the ISRE activation driven 153 by IFN-αA/D in NIH3T3 cells was suppressed by the expression of mMARV VP40 (Fig.   154 3C). These results suggest that SFTSV NSs cannot interfere with type I IFN signaling in 155 murine cells. 156 We also examined the effect of NSs on IFN-αA/D-induced expression of mRNA 157 for two ISGs, ISG56 and oligoadenylate synthetase 1 (OAS1), by real-time qPCR. The 158 induction of both ISGs by IFN in HEK293T cells was suppressed by NSs expression, 159 whereas NSs did not suppress induction in NIH3T3 cells (Fig. 3D ).
161
NSs does not interact with murine and hamster STAT2. 162 SFTSV NSs inhibits type I IFN signaling by the interaction with human STAT1 163 (hSTAT1) and STAT2 (hSTAT2) (13-15). However, the interaction with hSTAT1 is 164 weaker than that with hSTAT2 (15). We also showed here that mice deficient for STAT2, 165 but not STAT1, were highly susceptible to SFTSV infection and progressed to severe disease (Fig1). Therefore, we suggest that NSs cannot interact with murine STAT2 and 167 thus cannot antagonize IFN signaling in murine cells. 168 First, to examine whether NSs interacts with murine STAT2 (mSTAT2), we 169 performed co-immunoprecipitation (co-IP) assays using lysates from cells transfected 170 with a NSs expression plasmid. As shown in Fig. 4A , co-IP of STAT2 with NSs was 171 observed only in the lysates from HEK293T cells, but not from NIH3T3 cells, 172 suggesting that NSs interact with hSTAT2 but not with mSTAT2. It was also indicated 173 that NSs bound to hSTAT1, but not to murine STAT1 (mSTAT1) ( Fig. 4A ). 174 We also examined the interaction of NSs with hamster STAT2 (hamSTAT2) by 175 co-IP assay, since Stat2 -/hamsters, like Stat2 -/mice, are highly susceptible to SFTSV 176 infection (19). As shown in Fig. 4B , the interaction of NSs with hamSTAT2, as well as 177 mSTAT2, was not observed.
178
The interaction of NSs with STAT2 was also examined by subcellular 179 colocalization of the proteins. The NSs expression plasmid was cotransfected with the 180 expression plasmids for hSTAT2, mSTAT2, or hamSTAT2 into HEK293T, NIH3T3, or 181 BHK-21 cells, respectively, and subcellular localizations of proteins were observed.
182
Cytoplasmic inclusion bodies (IBs), mainly formed by NSs, were also observed in 183 HEK293T, NIH3T3, and BHK-21 cells (Fig. 4C ). In HEK293T cells, hSTAT2 colocalizes with NSs, consistent with previous reports (13-15). On the other hand, in 185 NIH3T3 and BHK-21 cells, colocalization of NSs with mSTAT2 or hamSTAT2 was not 186 observed ( Fig. 4C ). These findings indicate that NSs interacts with hSTAT2, but not 187 mSTAT2 and hamSTAT2.
189
The N-terminal region of hSTAT2 is important for binding to NSs. 190 To investigate the difference in NSs binding between human and murine STAT2, 191 we prepared a series of chimeric proteins from hSTAT2 and mSTAT2 (Fig. 5A ). The data also indicates that NSs cannot interact with hamSTAT2. This result is consistent 254 with a previous report showed that STAT2-deficient hamsters are also highly susceptible 255 to SFTSV infection (19).
256
The relationship between NSs and STAT2 is reminiscent of that of dengue virus 257 NS5 and STAT2 (A23-25). Previous studies reported that innate immunity mediated by 258 mSTAT2 restricts dengue virus replication in mice (25-26). To block the type I IFN 259 signaling pathway in humans, dengue virus NS5 expression leads to the degradation of 260 hSTAT2 (25). However, NS5 cannot suppress type I IFN signaling in mice, because 261 mSTAT2 is resistance to NS5-mediated degradation (23-25). These results demonstrate 262 that STAT2 may be one of the determinants for the species specificity of dengue virus.
Here, we elucidated that SFTSV induces lethal disease in STAT2-deficient mice and that 264 NSs cannot interact with mSTAT2. Thus, similar to dengue virus NS5, the anti-STAT2 265 activity of NSs appears to determine the species specificity of SFTSV infection.
266
In this study, chimeric mutants of hSTAT2 and mSTAT2 revealed that residues 267 101-315 of hSTAT2 are required for the interaction with NSs or that these residues in 268 mSTAT2 interfere with the interaction with NSs. We also confirmed that mSTAT2 and 269 all of the chimeric mutants of hSTAT2 and mSTAT2 used in this study can activate 270 ISRE-mediated gene expression as functional STAT2 proteins. Previously, Ning et al. 271 reported that the DBD region (316-485) of hSTAT2 is required for the interaction with 272 NSs (13). However, we showed that mutants possessing the DBD region of mSTAT2, 273 HMM, and H(101-315)MM, can still bind to NSs ( Fig. 5 ). At present, we cannot 274 explain this result, although this discrepancy may be explained by the differences in the 275 three-dimensional protein structure between our mutants and Ning's deletion mutants.
276
Further analyses will be required to clarify this issue.
277
Taken together, we conclude that the anti-STAT2 activity of NSs determines the 278 species specificity of SFTSV infection. In addition, we show that Stat2 -/mice, as well 
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284
Ethics statement. 285 Our research protocol for the use of mice follows the Nagasaki University Regulations 286 for Animal Care and Use, which was approved by the Animal Experiment Committee of 287 Nagasaki University (approval number; 151110-1-5). (Invitrogen) with a hemagglutinin (HA) tag using the primers listed in Table 1 to 341 produce pcDNA3.1/NSs-HA. To prepare the expression plasmids for 6xHistidine 342 (His)-tagged hSTAT2 (pcDNA3.1/hSTAT2-His), mSTAT2 (pcDNA3.1/mSTAT2-His), 343 and hamSTAT2 (pcDNA3.1/hamSTAT2-His), the desired genes were amplified by 344 RT-PCR using the primers listed in Table 1 from the cDNA of HEK293T, NIH3T3, and 345 BHK-21 cells, respectively. The expression plasmids for the series of STAT2 chimeras 346 were constructed using an In-Fusion HD Cloning kit (TaKaRa) with the primers listed 347 in Table 1 . The expression plasmid for mMARV VP40 was constructed from MARV 348 VP40 (28) using a KOD-Plus-Mutagenesis Kit (TOYOBO) using the primers listed in 349 Table 1 . Immunofluorescence assay (IFA). 408 The expression plasmids for His-tagged hSTAT2, mSTAT2, hamSTAT2, or a series of STAT2 chimeras were cotransfected into HEK293T, NIH3T3, or BHK-21 cells with the (Fig 3B and 6) . for His-tagged hSTAT2, mSTAT2, or hamSTAT2, respectively. IFA was also performed 597 with NSs, STAT2, and the nuclei shown in green, red, and blue, respectively. 
